Related Experiment Video
Updated: Jun 14, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
Can antioxidants be effective therapeutics?
Helena M Cochemé1, Michael P Murphy
1University College London, Institute of Healthy Ageing, Department of Genetics, Evolution and Environment, Gower Street, London, WC1E 6BT, UK.
Abstract:
Despite evidence that oxidative damage contributes to a wide range of clinically important pathologies, few antioxidants act as effective pharmaceuticals in vivo. The reasons for this therapeutic inefficacy include the challenge of targeting antioxidants to particular organs and intracellular locations, as well as the problem of matching the reactivity of antioxidants to the relevant damaging species in vivo. The difficulty of measuring antioxidant efficacy in vivo also makes the interpretation of results from clinical trials difficult. In this review, the challenges associated with antioxidant drug development are presented, and approaches to overcome these issues in order to design more effective therapeutic antioxidants are discussed.
Insights
Developing effective antioxidant drugs faces challenges in targeting and reactivity. This review discusses overcoming these hurdles for better therapeutic antioxidants in vivo.
Area of Science:
- Biochemistry
- Pharmacology
- Oxidative Stress Research
Background:
- Oxidative damage is implicated in numerous pathologies.
- Current antioxidants show limited therapeutic efficacy in vivo.
- Key challenges include targeting and reactivity matching.
Purpose of the Study:
- To review challenges in antioxidant drug development.
- To discuss strategies for enhancing therapeutic efficacy.
- To guide the design of novel antioxidant pharmaceuticals.
Main Methods:
- Literature review of antioxidant research.
- Analysis of in vivo drug delivery and efficacy studies.
- Discussion of biochemical and pharmacological principles.
Main Results:
- Antioxidant efficacy is hindered by poor organ/cellular targeting.
- Matching antioxidant reactivity to specific damaging species is difficult.
- Measuring in vivo antioxidant effectiveness complicates clinical trial interpretation.
Conclusions:
- Overcoming targeting and reactivity challenges is crucial for effective antioxidant drugs.
- Novel strategies are needed to improve in vivo antioxidant performance.
- Further research can lead to more successful antioxidant therapies.
Related Concept Videos
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Radical Autoxidation
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Bioactivation and Tissue Toxicity
Atherosclerosis III: Management
